Fig. 4.
Characterization of albumin conjugates. (A) MALDI-TOF/MS spectra of Alb(Peg4-DBCO)n (n = DOF) conjugates. (B) Change of DOF measured by MALDI-TOF/MS with respect to the molar equiv. of NHS-Peg4-DBCO. (C) MALDI-TOF/MS spectra of Alb–paclitaxel conjugates and Alb–Paclitaxel–DBCO conjugates.